DNA-responsive polymer gels used for releasing drugs, encapsulating cells, and much more now have greater adaptability thanks to the Cas12a nuclease.

A novel system for customizable DNA-hydrogel manipulations

Two clinical trial participants—one with β-thalassemia and one with sickle cell disease—appeared to benefit from the gene-editing treatments with minimal side effects, according to the companies.

New technology is required to increase bioenergy production. CRISPR may be the answer.

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

In demonstrations in cell lines, the technique has a similar efficacy to CRISPR-Cas9, but fewer off-target effects.

The research, led by Russian biologist Denis Rebrikov, has not led to the birth of gene-edited babies—yet.

Genetically engineered Drosophila withstand toxins common in monarch butterflies’ diet.

The authors have requested a retraction of a paper that found people with the CCR5 Δ32 variant are more likely to die sooner.